The Indian pharmaceuticals market is expected to touch $55 billion by 2020 from $36.7 billion in 2016, growing at a compound annual growth rate (CAGR) of 15.92%, according to a new report.
Indian pharmaceuticals market increased at a CAGR of 17.46% during 2005-16 with the market increasing from $6 billion in 2005 to $36.7 billion in 2016. By 2020, India is likely to be among the top three pharmaceutical markets by incremental growth and sixth largest market globally in absolute size, noted the study titled `Medical Value Travel (MVT),` jointly conducted by the Associated Chambers of Commerce & Industry (ASSOCHAM) and research firm Indian Institute of Tourism and Travel Management (IITTM).
According to the report, Indian Health Care is expected to rise at a CAGR of 29% during 2015-20 to $280 billion with rising income, greater health awareness, increased precedence of lifestyle diseases and improved access to insurance.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze